| Resistant (N = 16) N (%) | Responder (N = 42) N (%) | p |
---|---|---|---|
Demographics | Â | Â | Â |
 Sex (M/F) | 9/7 | 24/18 | 1 |
 Age (mean) | 33 | 29 | 0.32 |
 < 12 months | 8 (50) | 11 (26) | 0.12 |
 12–23 months | 1 (6) | 10 (24) | 0.26 |
 ≥ 24 months | 7 (44) | 21 (50) | 0.77 |
Clinics | |||
 Fever length before Ig (days) | 6 [5–8] | 7 [6–8] | .35 |
 Lymphadenopathy | 7 (44) | 17 (40) | 1 |
 Rash | 11 (69) | 32 (76) | .74 |
 Conjunctivitis | 12 (75) | 25 (60) | .37 |
 Enanthem | 8 (50) | 30 (71) | .14 |
 Modification of the extremities | 5 (31) | 22 (52) | .24 |
 Fever length after Ig (hours) | 62 [58–64] | 24 [20–36] | <  10−10 |
Biology | |||
Platelets | 463,500 | 405,900 | .61 |
Neutrophils (%) | 66 | 64 | .47 |
Hemoglobin (g/dl) | 10.3 | 10.3 | .91 |
 CRP (mg/L) | 172 | 140 | .23 |
 ΔCRP (%) | 48 | 62 | .08 |
 ASAT (UI/L) | 46 | 61 | .31 |
 ALAT (UI/L) | 49 | 81 | .15 |
 Bilirubin (μmol/L) | 17 | 10 | .54 |
 LDH (UI/L) | 855 | 636 | .66 |
 Albumin (g/L) | 26 | 27 | .96 |
 Sodium (mmol/L) | 136 | 136 | .70 |
Scores | |||
 Kobayashi |  |  | .66 |
  <  5 | 10 (91) | 29 (81) |  |
  ≥ 5 | 1 (9) | 7 (19) |  |
 Egami |  |  | 1 |
  < 3 | 9 (75) | 26 (72) |  |
  ≥ 3 | 3 (25) | 10 (28) |  |
 Sano |  |  | .69 |
  < 2 | 5 (63) | 23 (70) |  |
  ≥ 2 | 3 (37) | 10 (30) |  |
Treatments | |||
 1st dose IV Ig | 15 (100) | 43 (100) | 1 |
 2nd dose IV Ig | 5 (33) | 0 (0) | .0009 |
 Corticosteroids | 5 (33) | 1 (2) | .004 |
First echocardiogram results | |||
 Normal | 4 (25) | 25 (60) | .04 |
 Abnormal | 12 (75) | 17 (40) | .04 |
 Coronary artery dilatation | 4 (25) | 5 (12) | .24 |
 Pericardial effusion | 3 (19) | 6 (14) | .70 |
 Perivascular brightness of the coronary arteries | 1 (7) | 2 (5) | .53 |
 CAA | 1 (7) | 2 (5) | .53 |
  Small (<  5 mm) | 0 | 1 |  |
  Median (5–8 mm) | 0 | 1 |  |
  Giant (>  8 mm) | 1 | 0 |  |
 Left ventricular dysfunction | 1 | 2 |  |
  Mitral insufficiency | 0 | 0 |  |
Abnormal late echocardiograms | |||
 6 weeks | 8 (50) | 5 (12) | .03 |
  Coronary artery dilatation | 5 (31) | 1 (2) | .004 |
  Pericardial effusion | 1 (7) | 0 | .28 |
  Perivascular brightness of the coronary arteries | 0 | 0 | 1 |
  CAA | 2 (13) | 4 (9) | .66 |
   Small (<  5 mm) | 0 | 2 |  |
   Median (5–8 mm) | 1 | 2 |  |
   Giant (>  8 mm) | 1 | 0 |  |
 Long-term | 3 (19) | 2 (5) | .12 |
  Coronary artery dilatation | 2 | 0 |  |
   CAA | 1 | 2 |  |
   Small (<  5 mm) | 1 | 2 |  |
   Median (5–8 mm) | 0 | 0 |  |